-transparent.png){kind=logo}
Conventional therapy for colorectal carcinoma using 5-fluorouracil (5-FU) has shown limited antitumor action. The purpose of our study was to investigate synergistic antitumor effects of the streptococcal preparation of OK-432 and 5-FU, and to elucidate the mechanisms of interaction between the 2 agents in mice. Biochemical modulation of OK-432 and 5-FU were determined in vivo against colon-26 carcinoma. The concentration of 5-FU and its metabolites, and the activity of thymidylate synthase and thymidine kinase, respectively, were measured using cytosolic extracts of the tumors. Combination treatment with OK-432 produced a significant increase in intratumor 5-FU and 5-FU in RNA (F-RNA) concentrations, increased the thymidylate synthetase inhibition rate, and decreased thymidine kinase activity, as compared with the results observed in the control mice. These additive antitumor effects are obtained by use of the 2 agents; the mechanism of action is considered to be the suppression of both the de novo and the salvage pathway for DNA synthesis, along with the suppression of RNA synthesis.
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
January 1999,
Anticancer research,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
July 1981,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
January 1997,
Anticancer research,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
March 1997,
International journal of urology : official journal of the Japanese Urological Association,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
July 1986,
Gan to kagaku ryoho. Cancer & chemotherapy,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
April 1987,
Cancer,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
October 1979,
The Journal of urology,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
April 2005,
The Journal of dermatological treatment,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
January 1987,
Cancer immunology, immunotherapy : CII,
M Funaki, and
A Gouchi, and
H Iwagaki, and
Y Morimoto, and
H Shimamura, and
N Ariki, and
N Tanaka
November 1992,
Hinyokika kiyo. Acta urologica Japonica,
